FindTrial
Sign In

Effect of the drug dexmedetomidine used during a nasal surgery on the recovery of the patient while coming out of anesthesia

Efficacy of Intraoperative Dexmedetomidine Infusion on Emergence Agitation and Quality of Recovery After Nasal Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/06/025605
Enrollment
120
Registered
2020-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Control Intervention1: Dexmedetomidine: Alpha 1 agonist which is a anti anxiety drug,sedative and pain reducing medication... which will be given in very low dose throughout the procedure in the form

Sponsors

kasturba medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: age from 18 to 60 yrs asa 1-2 class undergoing elective nasal surgeries

Exclusion criteria

Exclusion criteria: known allergy to alpha 2 adrenergic agonist or nsaids use of MAO inhibitors or adrenergic blocking drugs history of uncontrolled hypertension cognitive impairment chronic use of anti psychotic kidney or liver disease bmi greater or equal to 30 kg/metre square

Design outcomes

Primary

MeasureTime frame
Improvement In Recovery And Emergence Agitation In Post Nasal Surgery Following Intraoperative Low Dose Dexmedetomidine InfusionTimepoint: The patient response is assessed immediately after extubation-at baseline—

Secondary

MeasureTime frame
Reduced Incidence In Post Operative Nausea And Vomiting in addition to smooth recoveryTimepoint: Assessed approximately upto 2 hours post extubation—

Countries

India

Contacts

Public Contactsita mukkavilli

Kasturba Medical College

drsunilbv@gmail.com9620178559

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026